Creating a new treatment for melioidosis
Development of a Novel Therapeutic for Melioidosis
This study is working on a new treatment for melioidosis, a serious infection, and it will involve patients to see how well the new medicine works and if it's safe for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | An2 Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11090309 on NIH RePORTER |
What this research studies
This research focuses on developing a new therapeutic option for melioidosis, a serious infectious disease caused by the bacterium Burkholderia pseudomallei. The project involves various stages of drug development, including optimizing potential drug candidates, conducting preclinical studies, and assessing safety and efficacy in clinical settings. Patients may be involved in trials to evaluate how well the new treatment works and its safety profile. The research aims to provide a more effective treatment for those affected by this disease.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals diagnosed with melioidosis or those at high risk of infection.
Not a fit: Patients with other unrelated infectious diseases or those not diagnosed with melioidosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective treatment for melioidosis, improving patient outcomes and survival rates.
How similar studies have performed: Previous research has shown promise in developing therapeutics for similar infectious diseases, indicating potential for success in this area.
Where this research is happening
Menlo Park, United States
- An2 Therapeutics, INC. — Menlo Park, United States (Active)
Researchers
- Principal investigator: Alley, M.r.k. (Dickon) — An2 Therapeutics, INC.
- Study coordinator: Alley, M.r.k. (Dickon)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.